MOLLI Surgical’s Award-Winning Technology can help Overloaded Hospitals with Greater Efficiency, Increased Accessibility, More Flexible Scheduling, and a Better Patient Experience

One way to help solve the backlog for Canada’s overloaded hospitals is to adopt technology that makes surgeries more efficient while improving the patient experience. MOLLI Surgical is improving localization — the process of identifying and marking the location of a lesion in soft tissue such as the breast.

Today, many hospitals use a wire-guided method introduced in the 1970s. A fine wire is inserted to mark the lesion, but comes with pain, fasting, and rigid scheduling since localization and surgery must be done on the same day. MOLLI Surgical’s Health Canada-approved and FDA-cleared MOLLI® is a precise, easy to use, wire-free technology for soft-tissue localization.

The MOLLI Marker® is inserted by needle, and then detected using the MOLLI Wand®. The MOLLI Tablet® displays their locations, helping surgeons remove lesions more efficiently with improved precision. The localization procedure takes five minutes, and the surgery window grows to 30 days. By "decoupling" localization from surgery, care teams can increase the scheduling capacity of radiology departments (up to 34%) and increase breast-conserving surgery programs (up to 41%), improving workflows and creating a better patient experience.

MOLLI was recognized with a gold medal in the 2022 Medical Design Excellence Awards, named as one of TIME Magazine’s Best Inventions of 2022, and one of the Next Big Things in Tech by Fast Company. MOLLI’s wire-free localization provides a better experience before, during, and after surgery for patients, hospital administrators, the radiologist who helps to locate the lesion, and the surgeon who has to remove it.

For more information: CAN Health press release;    http://mollisurgical.com